- Home
- GHG vs KOD Comparison
GHG vs KOD Comparison
Compare GHG & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- KOD
- Stock Information
- Founded
- GHG 2004
- KOD 2009
- Country
- GHG China
- KOD United States
- Employees
- GHG N/A
- KOD N/A
- Industry
- GHG Hotels/Resorts
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GHG Consumer Discretionary
- KOD Health Care
- Exchange
- GHG Nasdaq
- KOD Nasdaq
- Market Cap
- GHG 202.0M
- KOD 188.9M
- IPO Year
- GHG 2018
- KOD 2018
- Fundamental
- Price
- GHG $2.10
- KOD $3.77
- Analyst Decision
- GHG
- KOD Hold
- Analyst Count
- GHG 0
- KOD 3
- Target Price
- GHG N/A
- KOD $9.00
- AVG Volume (30 Days)
- GHG 12.9K
- KOD 292.9K
- Earning Date
- GHG 08-14-2025
- KOD 08-13-2025
- Dividend Yield
- GHG 4.85%
- KOD N/A
- EPS Growth
- GHG N/A
- KOD N/A
- EPS
- GHG 0.15
- KOD N/A
- Revenue
- GHG $184,055,595.00
- KOD N/A
- Revenue This Year
- GHG $19.02
- KOD N/A
- Revenue Next Year
- GHG $8.26
- KOD N/A
- P/E Ratio
- GHG $14.22
- KOD N/A
- Revenue Growth
- GHG N/A
- KOD N/A
- 52 Week Low
- GHG $1.93
- KOD $1.92
- 52 Week High
- GHG $3.40
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- GHG 50.15
- KOD 48.88
- Support Level
- GHG $1.97
- KOD $3.55
- Resistance Level
- GHG $2.13
- KOD $3.94
- Average True Range (ATR)
- GHG 0.10
- KOD 0.25
- MACD
- GHG 0.00
- KOD -0.01
- Stochastic Oscillator
- GHG 52.00
- KOD 31.40
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.